Guangxun Gao

1.4k total citations
65 papers, 802 citations indexed

About

Guangxun Gao is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Guangxun Gao has authored 65 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 23 papers in Hematology and 22 papers in Oncology. Recurrent topics in Guangxun Gao's work include Multiple Myeloma Research and Treatments (14 papers), Lymphoma Diagnosis and Treatment (10 papers) and Ubiquitin and proteasome pathways (8 papers). Guangxun Gao is often cited by papers focused on Multiple Myeloma Research and Treatments (14 papers), Lymphoma Diagnosis and Treatment (10 papers) and Ubiquitin and proteasome pathways (8 papers). Guangxun Gao collaborates with scholars based in China, United States and Canada. Guangxun Gao's co-authors include Xiequn Chen, Hongtao Gu, Hongjuan Dong, Baoxia Dong, Chuanshu Huang, Liang Chen, Ying Gao, Jingxia Li, Hailong Tang and Li Xu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Guangxun Gao

61 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guangxun Gao China 17 463 192 169 149 113 65 802
Anjian Xu China 18 547 1.2× 173 0.9× 149 0.9× 64 0.4× 167 1.5× 53 941
Diana Saleiro United States 16 362 0.8× 238 1.2× 108 0.6× 93 0.6× 76 0.7× 30 813
Yun Leng China 13 433 0.9× 129 0.7× 88 0.5× 172 1.2× 110 1.0× 48 655
Thomas S. K. Wan Hong Kong 19 630 1.4× 226 1.2× 70 0.4× 194 1.3× 276 2.4× 56 1.1k
Houda Alachkar United States 20 613 1.3× 192 1.0× 50 0.3× 190 1.3× 156 1.4× 60 1.0k
Gertraud Fröschl Austria 15 597 1.3× 269 1.4× 120 0.7× 401 2.7× 111 1.0× 17 1.3k
Yoshiko Hoshikawa Japan 20 499 1.1× 263 1.4× 189 1.1× 39 0.3× 95 0.8× 50 1.1k
Kazuto Togitani Japan 13 474 1.0× 266 1.4× 63 0.4× 248 1.7× 60 0.5× 30 892
Jehng-Kang Wang Taiwan 18 295 0.6× 134 0.7× 57 0.3× 142 1.0× 208 1.8× 40 854
Yogesh Tengarai Ganesan United States 7 555 1.2× 182 0.9× 85 0.5× 35 0.2× 106 0.9× 8 719

Countries citing papers authored by Guangxun Gao

Since Specialization
Citations

This map shows the geographic impact of Guangxun Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangxun Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangxun Gao more than expected).

Fields of papers citing papers by Guangxun Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangxun Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangxun Gao. The network helps show where Guangxun Gao may publish in the future.

Co-authorship network of co-authors of Guangxun Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Guangxun Gao. A scholar is included among the top collaborators of Guangxun Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangxun Gao. Guangxun Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Jingwei, et al.. (2025). CMOEP regimen in the treatment of untreated peripheral T-cell lymphoma: a multicenter, single-arm, phase I study. Frontiers in Immunology. 16. 1551723–1551723. 1 indexed citations
2.
3.
4.
Sun, Chunyan, Guangxun Gao, Fuling Zhou, et al.. (2023). Interim Results of the Launch Study-a Multicenter, Open-Label Study of Selinexor, Dexamethasone and Chemotherapy Drugs in Relapsed/ Refractory Multiple Myeloma. Blood. 142(Supplement 1). 4763–4763. 1 indexed citations
5.
6.
Liu, Aijun, Lihong Liu, Wei Wang, et al.. (2023). Outcome and characteristics of nonsecretory multiple myeloma compared with secretory multiple myeloma: a retrospective multicenter study from China. BMC Cancer. 23(1). 930–930. 1 indexed citations
7.
Liu, Xiao, Zhengcong Cao, Nannan Liu, et al.. (2022). Kill two birds with one stone: Engineered exosome-mediated delivery of cholesterol modified YY1-siRNA enhances chemoradiotherapy sensitivity of glioblastoma. Frontiers in Pharmacology. 13. 975291–975291. 22 indexed citations
8.
Liu, Xiao, Shuangshuang Jia, Chunyan Zhang, et al.. (2022). Chromosome 1q21 gain is an adverse prognostic factor for newly diagnosed multiple myeloma patients treated with bortezomib-based regimens. Frontiers in Oncology. 12. 938550–938550. 3 indexed citations
9.
Xu, Tianqi, Li Xu, Panpan Wang, et al.. (2020). Primary lymphoma of bone: a population-based study of 2558 patients. Therapeutic Advances in Hematology. 11. 154250314–154250314. 11 indexed citations
10.
Dong, Yujun, Chunrui Li, Wenrong Huang, et al.. (2020). [Epidemiological analysis of cytogenetic abnormalities in patients with newly-diagnosed multiple myeloma: a multi-center retrospective study].. PubMed. 41(1). 10–15. 2 indexed citations
11.
Jin, Fengyan, Guangxun Gao, Yujun Dong, et al.. (2019). A Multi-Center Epidemiological and Prognostic Analysis of Cytogenetic Abnormalities in a Cohort of 1015 Chinese Patients with Newly-Diagnosed Multiple Myeloma. Blood. 134(Supplement_1). 3094–3094. 2 indexed citations
12.
Zheng, Yanhua, Yueyun Ma, Yi Ding, Xiequn Chen, & Guangxun Gao. (2018). An insight into new strategies to combat antifungal drug resistance. Drug Design Development and Therapy. Volume 12. 3807–3816. 29 indexed citations
13.
Xu, Li, Hailong Tang, Xiaoli Xin, et al.. (2015). [Inducing effect of chidamide on apoptosis of multiple myeloma cells and its relerance to DNA damage response].. PubMed. 23(2). 450–4. 6 indexed citations
14.
15.
16.
Pan, Yaozhu, Ying Gao, Liang Chen, et al.. (2011). Targeting Autophagy Augments In Vitro and In Vivo Antimyeloma Activity of DNA-Damaging Chemotherapy. Clinical Cancer Research. 17(10). 3248–3258. 77 indexed citations
17.
Gao, Guangxun, et al.. (2010). [Clinical analysis on 28 patients with hemophagocytic lymphohistiocytosis syndrome].. PubMed. 18(2). 463–5. 1 indexed citations
18.
Gao, Guangxun, Liang Chen, Baoxia Dong, et al.. (2009). RhoA effector mDia1 is required for PI 3-kinase-dependent actin remodeling and spreading by thrombin in platelets. Biochemical and Biophysical Research Communications. 385(3). 439–444. 15 indexed citations
19.
Dong, Hongjuan, Liang Chen, Xiequn Chen, et al.. (2009). Dysregulation of unfolded protein response partially underlies proapoptotic activity of bortezomib in multiple myeloma cells. Leukemia & lymphoma. 50(6). 974–984. 57 indexed citations
20.
Gu, Hongtao, Xiequn Chen, Guangxun Gao, & Hongjuan Dong. (2008). Caspase-2 functions upstream of mitochondria in endoplasmic reticulum stress-induced apoptosis by bortezomib in human myeloma cells. Molecular Cancer Therapeutics. 7(8). 2298–2307. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anjian Xu Breakdown of academic impact, for papers by Diana Saleiro Breakdown of academic impact, for papers by Yun Leng Breakdown of academic impact, for papers by Thomas S. K. Wan Breakdown of academic impact, for papers by Houda Alachkar Breakdown of academic impact, for papers by Gertraud Fröschl Breakdown of academic impact, for papers by Yoshiko Hoshikawa Breakdown of academic impact, for papers by Kazuto Togitani Breakdown of academic impact, for papers by Jehng-Kang Wang Breakdown of academic impact, for papers by Yogesh Tengarai Ganesan
Rankless by CCL
2026